KMB
NASDAQ · USDOne year, rebased to 100
KMB SPY XLP (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials · FY2025
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
KMB vs industry median
112 companies in Household & Personal ProductsEarnings delivery
Next report 2026-11-05 · consensus EPS $1.62Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| KMB Kimberly-Clark Corporation | $35.1B | 18.0x | 122.6% | 11.8% | −14.2% | −11.8% |
| KVUE Kenvue Inc. | $36.3B | 21.7x | 15.6% | 11.5% | +1.8% | +35.7% |
| EL The Estée Lauder Companies | $37.9B | 205.0x | 4.7% | -3.2% | +5.1% | +8.4% |
| CHD Church & Dwight Co., Inc. | $24.8B | 33.5x | 17.0% | 13.3% | +2.7% | +21.4% |
| CL Colgate-Palmolive Company | $75.0B | 37.0x | 434.3% | 12.9% | +5.2% | +21.3% |
| CLX The Clorox Company | $10.5B | 18.1x | 285.6% | 8.4% | −5.4% | — |
| ELF e.l.f. Beauty, Inc. | $6.7B | 113.4x | 6.0% | 13.9% | +31.2% | — |
| REYN Reynolds Consumer Products I | $4.8B | 13.9x | 15.5% | 9.4% | +2.7% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Weak).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where KMB sits among 20 scored companies in Household & Personal Products (0 = lowest value, 100 = highest). It is a position, not a grade.Valuation
| Measure | KMB | Industry percentile |
|---|---|---|
| P/E (TTM) | 18.0x | 18th |
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.73 | 57th |
| Price / sales | 2.1x | 53rd |
| Price / book | 20.1x | 89th |
| Price / tangible book | — | |
| Price / free cash flow | 13.7x | 31st |
| Price / operating cash flow | 10.5x | 44th |
| Enterprise value | $40.7B | 79th |
| EV / sales | 2.5x | 68th |
| EV / EBITDA | 13.3x | 25th |
| EV / EBIT | 16.5x | 21st |
| EV / free cash flow | 15.9x | 25th |
| Earnings yield | 5.6% | 89th |
| FCF yield | 7.3% | 74th |
| Operating cash flow yield | 9.5% | 63rd |
| Graham number (per share) | $26.32 | 64th |
Profitability (TTM)
| Measure | KMB | Industry percentile |
|---|---|---|
| Gross margin | 36.7% | 21st |
| EBITDA margin | 18.4% | 79th |
| Operating margin | 12.4% | 63rd |
| EBIT margin | 14.9% | 74th |
| Net margin | 11.8% | 89th |
| NOPAT margin | 8.7% | 63rd |
| FCF margin | 15.5% | 74th |
| Operating cash flow margin | 20.1% | 84th |
| R&D / revenue | 0.0% | 0th |
| SG&A / revenue | 22.5% | 16th |
| Stock comp / revenue | 0.8% | 44th |
| Effective tax rate | 29.5% | 89th |
Returns on capital
| Measure | KMB | Industry percentile |
|---|---|---|
| ROE (on average equity) | 129.4% | 89th |
| ROA | 11.1% | 89th |
| ROIC | 19.8% | 74th |
| ROCE | 21.3% | 84th |
| Return on tangible assets | 13.9% | 84th |
| Cash ROIC (OCF / invested capital) | 45.6% | 88th |
| Gross profitability (GP / assets) | 32.8% | 32nd |
| ROIC, 3-yr average | 20.0% | 94th |
| ROIC, 5-yr average | 23.2% | 100th |
| ROE, 5-yr average | 226.8% | 94th |
| Incremental ROIC | 109.1% | 89th |
Growth
| Measure | KMB | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | -12.3% | 0th |
| Revenue growth (QoQ) | 0.6% | 26th |
| Revenue CAGR, 3 yr | -6.6% | 0th |
| Revenue CAGR, 5 yr | -2.7% | 20th |
| Gross profit CAGR, 3 yr | -2.8% | 6th |
| Operating income CAGR, 3 yr | -3.3% | 25th |
| Net income growth (TTM YoY) | -19.5% | 40th |
| Net income CAGR, 3 yr | 6.0% | 50th |
| EPS growth (TTM YoY) | -19.5% | 40th |
| EPS CAGR, 3 yr | 6.6% | 50th |
| EPS CAGR, 5 yr | -0.1% | 67th |
| FCF growth (TTM YoY) | 21.8% | 38th |
| FCF CAGR, 3 yr | 2.3% | 38th |
| Operating cash flow CAGR, 3 yr | 1.5% | 43rd |
| Book value CAGR, 3 yr | 52.7% | 100th |
| Dividend CAGR, 3 yr | 1.3% | 58th |
| Sustainable growth rate | 18.3% | 91st |
Margin history & stability
| Measure | KMB | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | 36.0% | 16th |
| Operating margin, 3-yr average | 14.5% | 68th |
| Net margin, 3-yr average | 12.0% | 89th |
| FCF margin, 3-yr average | 13.6% | 84th |
| Revenue stability (0-1) | 0.28 | 5th |
| Earnings stability (0-1) | 0.18 | 26th |
| Margin stability (0-1) | 0.95 | 47th |
Liquidity (latest quarter)
| Measure | KMB | Industry percentile |
|---|---|---|
| Cash & short-term investments | $956.0M | 79th |
| Net cash (− = net debt) | −$5.6B | 21st |
| Working capital | −$634.0M | 11th |
| Current ratio | 0.91 | 16th |
| Quick ratio | 0.69 | 26th |
| Cash ratio (cash + ST investments / current liabilities) | 0.14 | 26th |
| Defensive interval (days) | 255 days | 53rd |
Leverage & solvency (latest quarter)
| Measure | KMB | Industry percentile |
|---|---|---|
| Total debt | $6.5B | 79th |
| Debt / equity | 3.72 | 89th |
| Net debt / equity | 3.18 | 89th |
| Debt / assets | 35.1% | 58th |
| Debt / capital | 78.8% | 89th |
| Debt / EBITDA | 2.13 | 25th |
| Net debt / EBITDA | 1.82 | 31st |
| Interest coverage (EBIT / interest) | 10.4x | 72nd |
| Cash interest coverage | 14.1x | 72nd |
| Debt payback (years of OCF) | 2.0 yrs | 31st |
| Liabilities / assets | 89.8% | 89th |
| IS credit model rating | A | |
| Implied credit spread (bps) | 150 | 21st |
Efficiency
| Measure | KMB | Industry percentile |
|---|---|---|
| Asset turnover | 0.94 | 79th |
| Fixed asset turnover | 2.38 | 6th |
| Inventory turnover | 6.8 | 95th |
| Receivables turnover | 8.6 | 42nd |
| Days sales outstanding | 43 days | 58th |
| Days inventory outstanding | 54 days | 5th |
| Days payables outstanding | 115 days | 74th |
| Cash conversion cycle (days) | −19 days | 11th |
| Capex / revenue | 4.7% | 88th |
| Capex / depreciation | 1.31 | 88th |
| Operating expense ratio | 27.6% | 22nd |
Cash flow & earnings quality
| Measure | KMB | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.70 | 64th |
| FCF / net income | 1.31 | 45th |
| FCF / operating cash flow | 76.8% | 44th |
| Capex / operating cash flow | 23.2% | 56th |
| Accruals ratio | -7.8% | 32nd |
| Sloan accruals ratio | 2.2% | 89th |
| Earnings quality score (0-1) | 0.75 | 9th |
Scores & forensic checks
| Measure | KMB | Industry percentile |
|---|---|---|
| IS score | 53 | 53rd |
| IS profitability | 56 | 68th |
| IS growth | 30 | 16th |
| IS value | 50 | 79th |
| IS momentum | 51 | 37th |
| IS risk (safety) | 80 | 63rd |
| IS quality | 57 | 58th |
| IS balance sheet | 44 | 47th |
| IS earnings quality | 73 | 68th |
| IS cash flow | 69 | 68th |
| Piotroski F-score (0-9) | 7 | 63rd |
| Altman Z-score | 3.3 | 68th |
| Beneish M-score | −2.95 | 21st |
| Ohlson O-score | −5.96 | 63rd |
| IS credit score | 72 | 79th |
Size (TTM)
| Measure | KMB | Industry percentile |
|---|---|---|
| Market cap | $35.1B | 79th |
| Revenue | $16.6B | 89th |
| EBITDA | $3.1B | 84th |
| Net income | $2.0B | 89th |
| Free cash flow | $2.6B | 89th |
| Total assets | $18.6B | 84th |
| Shareholders' equity | $1.8B | 58th |
| Employees | 36,000 | 89th |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Blades Suzana SVP and General Counsel |
— | 2,071 | — | — | 0 |
| 2026-09-01 | Blades Suzana SVP and General Counsel |
— | 562 | — | — | 0 |
| 2026-09-01 | Blades Suzana SVP and General Counsel |
— | 999 | — | — | 0 |
| 2026-09-01 | Blades Suzana SVP and General Counsel |
— | 1,812 | — | — | 0 |
| 2026-07-31 | Corsi Patricia Chief Growth Officer |
Option exercise | 966 | — | — | 2,065 |
| 2026-07-31 | Corsi Patricia Chief Growth Officer |
Tax withholding | 404 | $109.31 | $44,161 | 1,661 |
| 2026-07-31 | Corsi Patricia Chief Growth Officer |
Option exercise | 966 | — | — | 1,288 |
| 2026-07-31 | Slavtcheff Craig Chief R&D Officer |
Option exercise | 4,024 | — | — | 7,641 |
| 2026-07-31 | Slavtcheff Craig Chief R&D Officer |
Option exercise | 1,255 | — | — | 8,896 |
| 2026-07-31 | Slavtcheff Craig Chief R&D Officer |
Tax withholding | 534 | $109.31 | $58,372 | 8,362 |
| 2026-07-31 | Slavtcheff Craig Chief R&D Officer |
Tax withholding | 1,711 | $109.31 | $187,029 | 6,651 |
| 2026-07-31 | Slavtcheff Craig Chief R&D Officer |
Option exercise | 4,024 | — | — | 0 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 23 | 334,391 | — |
| Open-market sale | Disposed | 3 | 7,096 | $689,696 |
| Option exercise | Disposed | 32 | 94,232 | — |
| Option exercise | Acquired | 32 | 94,232 | — |
| Tax withholding | Disposed | 32 | 91,373 | $9.0M |
| — | Disposed | 5 | 5,444 | — |
Form 144 notices
12 months: 6 notices · 18,034 shares · $1.8M| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2026-06-15 | Grant Mcgee | 6,144 | $634,540 |
| 2026-05-06 | Andrew Scribner | 4,095 | $401,179 |
| 2026-05-04 | Katy Chen | 1,596 | $152,113 |
| 2026-04-30 | Katy Chen | 1,405 | $136,176 |
Congress trades
12 months: House 11 trades (4 purchases) · Senate 0 (0 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | House | Purchase | $1,001 - $15,000 | 2026-10-09 |
| 2026-08-18 | Kevin Hern | House | Sale | $1,001 - $15,000 | 2026-09-02 |
| 2026-08-18 | Kevin Hern | House | Sale (Full) | $1,001 - $15,000 | 2026-09-02 |
| 2026-08-17 | Kevin Hern | House | Sale (Full) | $1,001 - $15,000 | 2026-09-02 |
| 2024-10-29 | Tommy Tuberville | Senate | Sale | $15,001 - $50,000 | 2026-08-05 |
| 2024-10-29 | Thomas Hawley Tuberville | Senate | Sale | $15,001 - $50,000 | 2026-08-05 |
| 2024-10-29 | Tommy Tuberville | Senate | Sale (Full) | $15,001 - $50,000 | 2024-11-15 |
| 2024-10-29 | Tommy Tuberville | Senate | Sale (Full) | $15,001 - $50,000 | 2024-11-14 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| BlackRock, Inc. | 32,321,354 | $3.5B | 9.72% |
| VANGUARD CAPITAL MANAGEMENT LLC | 21,661,695 | $2.4B | 6.51% |
| STATE STREET CORP | 21,081,552 | $2.3B | 6.34% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 16,099,649 | $1.8B | 4.84% |
| FMR LLC | 13,133,613 | $1.4B | 3.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,199,927 | $1.2B | 3.37% |
| Sixth Street Partners Management Company, L.P. | 10,812,642 | $1.2B | 3.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 10,812,642 | $1.2B | 3.25% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 8,156,490 | $894.9M | 2.45% |
| TWO SIGMA INVESTMENTS, LP | 7,054,632 | $774.4M | 2.12% |
| BANK OF AMERICA CORP /DE/ | 6,881,641 | $755.4M | 2.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 6,486,357 | $712.0M | 1.95% |
| NORGES BANK | 5,773,617 | $633.8M | 1.74% |
| THORNBURG INVESTMENT MANAGEMENT INC | 5,760,888 | $632.4M | 1.73% |
| AMERICAN CENTURY COMPANIES INC | 5,607,923 | $615.6M | 1.69% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1,723 | 100.2% | 202 | 634 | 629 | 117 |
| 2026-03-31 | 1,656 | 89.0% | 185 | 623 | 584 | 183 |
| 2025-12-31 | 1,686 | 86.5% | 232 | 538 | 694 | 227 |
| 2025-09-30 | 1,723 | 80.3% | 120 | 583 | 693 | 136 |
| 2025-06-30 | 1,773 | 79.9% | 120 | 644 | 644 | 146 |
| 2025-03-31 | 1,821 | 78.4% | 165 | 601 | 754 | 109 |
| 2024-12-31 | 1,792 | 79.0% | 214 | 625 | 671 | 129 |
| 2024-09-30 | 1,740 | 77.8% | 120 | 578 | 712 | 95 |
| 2024-06-30 | 1,737 | 78.0% | 156 | 556 | 724 | 87 |
| 2024-03-31 | 1,694 | 78.2% | 141 | 579 | 713 | 106 |
| 2023-12-31 | 1,680 | 77.4% | 191 | 488 | 738 | 76 |
| 2023-09-30 | 1,596 | 77.5% | 95 | 562 | 633 | 154 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-05-12 | SCHEDULE 13G | STATE STREET CORPORATION | 6.5% | 21,659,182 |
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.5% | 24,917,833 |
| 2026-04-24 | SCHEDULE 13G/A | BlackRock, Inc. | 8.8% | 29,295,775 |
| 2025-07-29 | SCHEDULE 13G/A | The Vanguard Group | 12.2% | 40,426,736 |
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.04% | $1.0B |
| VSMPX | 0.04% | $1.0B |
| VTI | 0.04% | $1.0B |
| VTSAX | 0.04% | $1.0B |
| SCHD | 0.83% | $932.3M |
| VOO | 0.05% | $850.8M |
Share structure
Income statement
Fiscal years, USD| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $19.4B | $20.2B | $20.4B | $20.1B | $17.2B |
| Cost of revenue | $13.5B | $14.0B | $13.4B | $12.9B | $11.1B |
| Gross profit | $6.0B | $6.2B | $7.0B | $7.2B | $6.1B |
| R&D | $269.0M | $292.0M | $312.0M | $338.0M | $0 |
| SG&A | $3.0B | $3.3B | $4.1B | $4.3B | $3.6B |
| Operating income | $2.6B | $2.7B | $2.3B | $3.2B | $2.5B |
| EBITDA | $3.2B | $3.4B | $3.1B | $4.0B | $3.1B |
| Pretax income | $2.2B | $2.3B | $2.0B | $2.9B | $2.2B |
| Income tax | $479.0M | $495.0M | $453.0M | $565.0M | $527.0M |
| Net income | $1.8B | $1.9B | $1.8B | $2.5B | $2.0B |
| EPS, diluted | $5.35 | $5.72 | $5.21 | $7.55 | $6.07 |
| Diluted shares | 338.8M | 338.3M | 338.8M | 337.0M | 333.1M |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $270.0M | $427.0M | $1.1B | $1.0B | $688.0M |
| Receivables | $2.2B | $2.3B | $2.1B | $2.0B | $1.9B |
| Inventory | $2.2B | $2.3B | $2.0B | $1.8B | $1.5B |
| Total current assets | $5.6B | $5.7B | $5.7B | $5.6B | $5.3B |
| PP&E, net | $8.1B | $7.9B | $7.9B | $7.5B | $6.8B |
| Goodwill & intangibles | $2.6B | $2.9B | $2.3B | $2.1B | $1.9B |
| Total assets | $17.8B | $18.0B | $17.3B | $16.5B | $17.2B |
| Accounts payable | $3.8B | $3.8B | $3.7B | $3.7B | $3.4B |
| Total current liabilities | $6.7B | $7.3B | $6.9B | $7.0B | $7.1B |
| Long-term debt | $8.1B | $7.6B | $7.4B | $6.9B | $6.5B |
| Total liabilities | $17.1B | $17.3B | $16.3B | $15.6B | $15.6B |
| Shareholders' equity | $737.0M | $700.0M | $1.1B | $975.0M | $1.7B |
Cash flow statement
Outflows are negative| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | $1.8B | $2.0B | $1.8B | $2.6B | $2.0B |
| Depreciation & amortization | $766.0M | $754.0M | $753.0M | $781.0M | $805.0M |
| Stock-based compensation | $26.0M | $150.0M | $169.0M | $131.0M | $140.0M |
| Change in working capital | $46.0M | −$17.0M | $569.0M | $178.0M | −$480.0M |
| Operating cash flow | $2.7B | $2.7B | $3.5B | $3.2B | $2.8B |
| Capital expenditure | −$1.0B | −$876.0M | −$766.0M | −$721.0M | −$1.1B |
| Free cash flow | $1.7B | $1.9B | $2.8B | $2.5B | $1.6B |
| Investing cash flow | −$1.1B | −$785.0M | −$418.0M | −$100.0M | −$951.0M |
| Net debt issued / repaid | $239.0M | −$51.0M | −$483.0M | −$553.0M | −$275.0M |
| Buybacks | −$400.0M | −$100.0M | −$225.0M | −$1.0B | −$141.0M |
| Dividends paid | −$1.5B | −$1.6B | −$1.6B | −$1.6B | −$1.7B |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Gross margin | 30.8% | 30.8% | 34.4% | 35.8% | 35.6% |
| Operating margin | 13.2% | 13.3% | 11.5% | 16.4% | 14.5% |
| Net margin | 9.3% | 9.6% | 8.6% | 12.7% | 11.7% |
| FCF margin | 8.9% | 9.2% | 13.6% | 12.5% | 13.8% |
| ROE | 318.2% | 364.6% | 241.3% | 290.0% | 172.6% |
| ROIC | 22.5% | 24.4% | 22.9% | 34.4% | 23.8% |
| ROA | 10.3% | 10.8% | 10.0% | 15.0% | 12.0% |
| Debt / equity | 16.93 | 15.63 | 8.87 | 9.42 | 4.77 |
| Interest coverage | 9.7x | 9.3x | 7.9x | 11.8x | 9.7x |
| Current ratio | 0.82 | 0.78 | 0.82 | 0.80 | 0.75 |
| Revenue growth | +1.6% | +3.8% | +1.3% | −1.8% | −14.2% |
| EPS growth | −22.2% | +6.5% | −8.9% | +46.3% | −20.3% |
| P/E at year end | 23.2x | 21.5x | 21.9x | 16.7x | 16.6x |
| EV / EBITDA at year end | 15.6x | 14.7x | 14.9x | 12.4x | 12.2x |
| FCF yield at year end | 4.09% | 4.47% | 7.18% | 5.90% | 7.08% |
| Dividend payout | 83.6% | 80.6% | 90.0% | 64.0% | 82.1% |
Revenue by segment
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Personal Care | $10.3B | $10.6B | $10.7B | — | — |
| Diapers | — | — | — | — | $6.8B |
| Consumer Tissue | $6.0B | $6.2B | $6.3B | $6.2B | — |
| Consumer tissue products | — | — | — | — | $4.1B |
| K-C Professional | $3.1B | $3.3B | $3.4B | — | — |
| Adult care products | — | — | — | — | $1.9B |
| Away from Home Professional Products | — | — | — | — | $1.8B |
| Feminine care products | — | — | — | — | $1.7B |
Street estimates by fiscal year
Next report 2026-11-05 · consensus EPS $1.62 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $16.6B | $16.4B – $16.8B | $7.34 | $7.27 – $7.44 | 8 | 14.4x |
| 2027 | $17.0B | $14.3B – $27.6B | $7.35 | $7.25 – $7.55 | 7 | 14.4x |
| 2028 | $17.4B | $17.1B – $17.7B | $7.91 | $7.51 – $9.07 | 1 | 13.4x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-08-04 | $2.01 | $1.80 | −10.4% | $4.2B | $4.2B | −0.8% |
| 2026-04-28 | $1.93 | $1.97 | +2.1% | $4.1B | $4.2B | +1.9% |
| 2026-01-27 | $1.81 | $1.86 | +2.8% | $4.1B | $4.1B | −0.3% |
| 2025-10-30 | $1.75 | $1.82 | +4.0% | $4.1B | $4.1B | +0.9% |
| 2025-08-01 | $1.67 | $1.92 | +15.0% | $4.8B | $4.2B | −14.1% |
| 2025-04-22 | $1.89 | $1.93 | +2.1% | $4.9B | $4.8B | −1.1% |
| 2025-01-28 | $1.51 | $1.50 | −0.7% | $4.9B | $4.9B | +1.5% |
| 2024-10-22 | $1.70 | $1.83 | +7.6% | $5.1B | $5.0B | −2.1% |
| 2024-07-23 | $1.71 | $1.96 | +14.6% | $5.1B | $5.0B | −1.3% |
| 2024-04-23 | $1.63 | $2.01 | +23.3% | $5.1B | $5.1B | +1.3% |
| 2024-01-24 | $1.54 | $1.51 | −1.9% | $5.0B | $5.0B | −0.3% |
| 2023-10-24 | $1.59 | $1.74 | +9.4% | $5.2B | $5.1B | −0.4% |
| 2023-07-25 | $1.48 | $1.65 | +11.5% | $5.1B | $5.1B | −0.0% |
| 2023-04-25 | $1.32 | $1.67 | +26.5% | $5.0B | $5.2B | +3.0% |
| 2023-01-25 | $1.51 | $1.54 | +2.0% | $5.0B | $5.0B | −0.4% |
| 2022-10-25 | $1.44 | $1.40 | −2.8% | $5.0B | $5.1B | +0.9% |
| 2022-07-26 | $1.32 | $1.34 | +1.5% | $5.0B | $5.1B | +1.5% |
| 2022-04-22 | $1.23 | $1.35 | +9.8% | $4.9B | $5.1B | +3.6% |
| 2022-01-26 | $1.24 | $1.30 | +4.8% | $4.9B | $5.0B | +0.4% |
| 2021-10-25 | $1.65 | $1.62 | −1.8% | $5.0B | $5.0B | +0.3% |
| 2021-07-23 | $1.71 | $1.47 | −14.0% | $5.0B | $4.7B | −5.5% |
| 2021-04-23 | $1.93 | $1.80 | −6.7% | $5.1B | $4.7B | −6.3% |
| 2021-01-25 | $1.60 | $1.69 | +5.6% | $4.6B | $4.8B | +6.0% |
| 2020-10-22 | $1.76 | $1.72 | −2.3% | $4.8B | $4.7B | −2.6% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $490.2M | 4,557,665 | 96,877 |
| 2026-08-24 | $417.6M | 3,777,305 | 85,062 |
| 2026-08-17 | $434.2M | 3,985,300 | 86,826 |
| 2026-08-10 | $280.8M | 2,574,207 | 68,760 |
| 2026-08-03 | $860.7M | 7,851,946 | 136,593 |
| 2026-07-27 | $494.0M | 4,429,877 | 99,022 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 56.1% | 2,215,123 | 3,945,418 |
| 2026-10-14 | 53.8% | 1,452,265 | 2,697,644 |
| 2026-10-13 | 64.2% | 1,901,083 | 2,961,503 |
| 2026-10-12 | 70.3% | 1,174,558 | 1,671,516 |
| 2026-10-09 | 63.0% | 1,437,353 | 2,283,087 |
| 2026-10-08 | 48.2% | 853,259 | 1,771,704 |
| 2026-10-07 | 54.6% | 721,726 | 1,322,986 |
| 2026-10-06 | 52.3% | 830,829 | 1,587,957 |
| 2026-10-05 | 57.0% | 788,345 | 1,382,208 |
| 2026-10-02 | 58.0% | 1,168,463 | 2,013,019 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| Jan | −0.7% | 35% | 20 |
| Feb | +0.4% | 50% | 20 |
| Mar | +1.2% | 62% | 21 |
| Apr | +1.8% | 65% | 20 |
| May | +0.1% | 50% | 20 |
| Jun | +1.1% | 65% | 20 |
| Jul | +0.1% | 45% | 20 |
| Aug | +0.9% | 60% | 20 |
| Sep | −0.3% | 60% | 20 |
| Oct | −0.6% | 40% | 20 |
| Nov | +2.9% | 85% | 20 |
| Dec | +0.3% | 60% | 20 |
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About Kimberly-Clark Corporation
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related products under the Huggies, Pull-Ups, Goodnites, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, Wypall , and other brand names. Its International Personal Care segment provides baby and child care, adult care and feminine care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Kotex, Goodfeel, Intimus, Depend, and other brand names. The company sells its household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce. It also sells its professional use products through distributors, directly to manufacturing, lodging, office building, food service, and high-volume public facilities, and through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Michael D. Hsu | Chairman & Chief Executive Officer | $3.8M | 1964 |
| Russell C. Torres | President & Chief Operating Officer | $2.0M | 1972 |
| Jeffrey Melucci | Chief Strategy, Business Development & Administrative Officer | $1.7M | 1971 |
| Nelson Urdaneta | Senior VP, CFO & Interim Principal Accounting Officer, | $1.7M | 1972 |
| Ehab Abou-Oaf | Chief Executive Officer of Arbex | — | 1967 |
| Francesco Tinto | Chief Information & Global Business Services Officer | — | — |
| Grant McGee | General Counsel | — | 1981 |
| Preeti Binoy | Head Corporate Communications & Government Affairs - India | — | — |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Michael D. Hsu Chairman of the Board and Chief Executive Officer | 2025 | $1.5M | $11.5M | $1.6M | $15.3M |
| Russell Torres President and Chief Operating Officer | 2025 | $950,150 | $4.3M | $616,000 | $6.3M |
| Nelson Urdaneta Senior Vice President and Chief Financial Officer | 2025 | $922,500 | $3.5M | $565,590 | $5.2M |
| Zackery Hicks Chief Digital and Technology Officer | 2025 | $1.0M | $3.0M | $638,570 | $4.9M |
| Jeffrey Melucci Chief Strategy, Business Development and Administrative Officer | 2025 | $914,250 | $3.1M | $614,790 | $4.9M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-09-04 | $1.28 | 2026-10-02 |
| 2026-06-05 | $1.28 | 2026-07-02 |
| 2026-03-06 | $1.28 | 2026-04-02 |
| 2025-12-05 | $1.26 | 2026-01-05 |
| 2025-09-05 | $1.26 | 2025-10-02 |
| 2025-06-06 | $1.26 | 2025-07-02 |
| 2025-03-07 | $1.26 | 2025-04-02 |
| 2024-12-06 | $1.22 | 2025-01-03 |